Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin79.3%0.0pp79.4%+0.2pp79.2%+1.0pp78.2%+0.6pp77.6%+1.9pp
Operating margin3.3%+0.6pp2.6%
Net margin0.7%-0.3pp1%
Returns
Return on equity0.7%-0.2pp1%
Return on invested capital2.7%+0.8pp1.9%
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×+0.1×0.4×0.0×0.4×0.0×
Liquidity
Current ratio4.7×+0.2×4.5×-0.7×5.3×+2.9×2.4×0.0×2.4×0.0×
Leverage
Debt-to-equity0.6×0.0×0.6×0.0×0.6×+0.1×0.5×0.0×0.4×-0.3×
Net debt / EBITDA2.3×0.0×2.4×
Per Share
Book value per share$15.98+3.9%$15.39-5.9%$16.36-1.9%$16.67-2.9%$17.16+2.0%
Valuation
Market capitalization$942.78M-16.0%$1.11B-3.8%$1.16B+1.6%$1.14B-0.9%$1.15B+32.2%
Price / earnings183.5×158.3×
Price / sales1.3×-0.3×1.5×-0.1×1.6×0.0×1.6×0.0×1.6×+0.4×
Price / book1.4×0.0×1.6×0.0×1.6×+0.1×1.5×+0.1×1.4×+0.3×
EV / EBITDA10.5×12.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pacira BioSciences, Inc.'s profit margins?
Pacira BioSciences, Inc. (PCRX) runs a 79.3% gross margin and a 3.3% operating margin, with a 0.7% net margin.
Where do Pacira BioSciences, Inc.'s ratios come from?
Every ratio is computed from Pacira BioSciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.